Total Payments
$1,965
2021 Payments
$100.00
Companies
21
Transactions
95
Medicare Patients
754
Medicare Billing
$59,909
Payment Breakdown by Category
Food & Beverage$1,965 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,965 | 95 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $486.52 | 16 | $0 (2020) |
| Gilead Sciences, Inc. | $406.69 | 14 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $187.84 | 15 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $128.49 | 9 | $0 (2018) |
| UCB, Inc. | $124.60 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 1 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $84.88 | 4 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $66.05 | 5 | $0 (2017) |
| PFIZER INC. | $60.55 | 4 | $0 (2020) |
| Janssen Biotech, Inc. | $55.47 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $100.00 | 1 | E.R. Squibb & Sons, L.L.C. ($100.00) |
| 2020 | $187.09 | 11 | AbbVie Inc. ($56.72) |
| 2019 | $266.33 | 16 | Gilead Sciences, Inc. ($68.96) |
| 2018 | $110.27 | 8 | Gilead Sciences, Inc. ($31.47) |
| 2017 | $1,302 | 59 | AbbVie, Inc. ($397.40) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular | ||||||
| 11/04/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: VIROLOGY | ||||||
| 09/09/2020 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Inflammation | ||||||
| 08/26/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 07/30/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: VIROLOGY | ||||||
| 07/08/2020 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Inflammation | ||||||
| 06/17/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: VIROLOGY | ||||||
| 06/16/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.08 | General |
| 06/03/2020 | Intercept Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 03/04/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $13.53 | General |
| Category: GI | ||||||
| 01/21/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 11/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.66 | General |
| 11/20/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 11/13/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 10/29/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.05 | General |
| 09/27/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 08/23/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/12/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Immunology | ||||||
| 07/26/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/19/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
| 06/14/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.81 | General |
| 05/31/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Immunology | ||||||
| 05/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 13 | 754 | 810 | $304,982 | $59,909 |
Total Patients
754
Total Services
810
Medicare Billing
$59,909
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 117 | 117 | $94,185 | $13,677 | 14.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 150 | 193 | $24,152 | $9,367 | 38.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 116 | 118 | $62,658 | $8,366 | 13.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 43 | 43 | $41,237 | $7,347 | 17.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 80 | 82 | $14,649 | $5,584 | 38.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 64 | $9,106 | $2,433 | 26.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $7,560 | $2,362 | 31.2% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 17 | 17 | $11,628 | $2,344 | 20.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 13 | 13 | $8,892 | $2,239 | 25.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 39 | 39 | $8,100 | $2,208 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 33 | $6,897 | $2,141 | 31.0% |
| 43450 | Dilation of esophagus | Facility | 2020 | 45 | 45 | $14,490 | $1,217 | 8.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 22 | 22 | $1,428 | $624.32 | 43.7% |
About Dr. Samuel Drake, M.D
Dr. Samuel Drake, M.D is a Specialist healthcare provider based in Seneca, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871546978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Drake, M.D has received a total of $1,965 in payments from pharmaceutical and medical device companies, with $100.00 received in 2021. These payments were reported across 95 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,965).
As a Medicare-enrolled provider, Drake has provided services to 754 Medicare beneficiaries, totaling 810 services with total Medicare billing of $59,909. Data is available for 1 year (2020–2020), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Seneca, SC
- Active Since 05/18/2006
- Last Updated 02/15/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1871546978
Products in Payments
- Epclusa (Drug) $228.64
- Viekira (Drug) $225.56
- PREPOPIK (Drug) $128.49
- Cimzia (Drug) $124.60
- ELIQUIS (Drug) $100.00
- Amitiza (Drug) $98.95
- Entyvio (Biological) $71.35
- Creon (Drug) $70.76
- Trulance (Drug) $66.05
- XIFAXAN (Drug) $60.96
- XELJANZ (Drug) $60.55
- Dexilant (Drug) $57.02
- MAVYRET (Drug) $56.72
- AVSOLA (Biological) $45.94
- STELARA (Biological) $40.78
- Humira (Biological) $38.69
- Linzess (Drug) $28.43
- APRISO (Drug) $26.49
- OCALIVA (Drug) $25.25
- Movantik (Drug) $22.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Seneca
Dr. John Hunter, Md, MD
Specialist — Payments: $26,820
Specialist $26,820
Stacy Jaskwhich, N.p, N.P
Specialist — Payments: $480.36
Specialist $480.36
Dr. Osceola Gilbert, M.d, M.D
Specialist — Payments: $76.73
Specialist $76.73
Stephanie Shepherd, Ma, MA
Specialist
Specialist
Ms. Asha Stremcha, Special Educ.teacher, SPECIAL EDUC.TEACHER
Specialist
Specialist
Jacquelyn Lee
Specialist
Specialist